Publication | Closed Access

Gefitinib plus Fuzheng Kang’ai Formula (扶正抗癌方) in Patients with Advanced Non-Small Cell Lung Cancer with Epidermal Growth Factor Receptor Mutation: A Randomized Controlled Trial

Fuzheng Kang ’MedicinePathologyRandomized Controlled TrialCancer TreatmentCancer GeneticsOncologyRadiation OncologyLung CancerMolecular OncologyCancer Growth